Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$132.76 USD
+1.43 (1.09%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $132.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ABT 132.76 +1.43(1.09%)
Will ABT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABT
Abbott (ABT) Gains As Market Dips: What You Should Know
Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Abbott (ABT) Stock Sinks As Market Gains: What You Should Know
NVST vs. ABT: Which Stock Should Value Investors Buy Now?
Other News for ABT
Slingshot Bullish appears for ABT after 1.79% move
ABT January 2028 Options Begin Trading
ABT forms 20 Day Moving Average Support on September 12
Bernstein Remains a Buy on Abbott Laboratories (ABT)
Crossed Above 20 Day Moving Average appears for ABT after 2.54% move